Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. CareDx, Inc
  6. Summary
    CDNA   US14167L1035

CAREDX, INC

(CDNA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/15/2021 06/16/2021 06/17/2021 06/18/2021 06/21/2021 Date
87.88(c) 88.7(c) 92.4(c) 88.64(c) 92.64 Last
473 593 540 940 646 721 1 431 036 290 689 Volume
-2.90% +0.93% +4.17% -4.07% +4.51% Change
More quotes
Financials (USD)
Sales 2021 278 M - -
Net income 2021 -17,9 M - -
Net cash position 2021 302 M - -
P/E ratio 2021 -259x
Yield 2021 -
Sales 2022 332 M - -
Net income 2022 -1,49 M - -
Net cash position 2022 334 M - -
P/E ratio 2022 -3 409x
Yield 2022 -
Capitalization 4 614 M 4 614 M -
EV / Sales 2021 15,5x
EV / Sales 2022 12,9x
Nbr of Employees 466
Free-Float 98,0%
More Financials
Company
CareDx, Inc. is a molecular diagnostics company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. The Company's commercialized testing solution, the AlloMap heart transplant molecular test (AlloMap), is a gene expression test that helps clinicians monitor and identify heart transplant recipients with... 
Sector
Biotechnology & Medical Research
Calendar
06/21 | 10:40amPresentation
More about the company
Ratings of CareDx, Inc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about CAREDX, INC
06/18CAREDX  : Material Modification to Rights of Security Holders (Form 8-K)
PU
06/18CAREDX, INC.  : Material Modification to Rights of Security Holders, Amendments ..
AQ
06/17CAREDX  : CEO Reg Seeto to Present at AAKP 4th Annual Policy Summit
AQ
06/16CareDx to Participate in Raymond James 2021 Human Health Innovation Conferenc..
GL
06/15CAREDX  : Hosts Fireside Chat with Pro Golfer and Heart Transplant Recipient Eri..
AQ
06/10INSIDER TRENDS : Selling By Insiders Lingers at CareDx
MT
06/09CareDx congratulates Hannah Valantine for her State of the Art Lecture at ATC..
GL
06/08CAREDX  : Buys Medication Management App Transplant Hero
MT
06/08CareDx To Acquire Transplant Hero Medication Management Application
GL
06/07CAREDX  : Presents Landmark KOAR-1000 Data, Demonstrating Higher 1-Year Graft Su..
AQ
06/04INSIDER TRENDS : CareDx Insider Sells for Tax Adds to 90-Day Selling Trend
MT
06/04INSIDER TRENDS : CareDx Insider Tax Sale Continues 90-Day Selling Trend
MT
06/04CareDx Presents Groundbreaking AlloSure® Data at the 2021 American Transplant..
GL
06/03CAREDX  : Advances Artificial Intelligence in Transplantation Partnership with O..
PU
06/03CAREDX, INC.  : Other Events (form 8-K)
AQ
More news
News in other languages on CAREDX, INC
2016CAREDX  : Un centre européen de suivi de la greffe cardiaque à Strasbourg
More news
Analyst Recommendations on CAREDX, INC
More recommendations
Chart CAREDX, INC
Duration : Period :
CareDx, Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CAREDX, INC
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Average target price 97,33 $
Last Close Price 88,64 $
Spread / Highest target 18,5%
Spread / Average Target 9,81%
Spread / Lowest Target 1,53%
EPS Revisions
Managers and Directors
NameTitle
Reginald Seeto President, Chief Executive Officer & Director
Ankur Dhingra Chief Financial & Accounting Officer
Peter K. Maag Chairman
Robert N. Woodward Vice President-Research & Development
Amitabh Shukla Senior Vice President-Technology
Sector and Competitors
1st jan.Capitalization (M$)
CAREDX, INC22.35%4 614
EXACT SCIENCES CORPORATION-4.51%21 705
GUARDANT HEALTH, INC.-6.73%12 155
BGI GENOMICS CO., LTD.-7.47%7 557
INVITAE CORPORATION-21.57%6 553
ADAPTIVE BIOTECHNOLOGIES CORPORATION-33.28%5 535